nach oben

Breast Cancer Research and Treatment

Erschienen in:

25.08.2016 | Review

Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence

verfasst von: Tong Li, Claudia Mello-Thoms, Patrick C. Brennan

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the most common neoplasm diagnosed amongst women worldwide and is the leading cause of female cancer death. However, breast cancer in China is not comprehensively understood compared with Westernised countries, although the 5-year prevalence statistics indicate that approximately 11 % of worldwide breast cancer occurs in China and that the incidence has increased rapidly in recent decades. This paper reviews the descriptive epidemiology of Chinese breast cancer in terms of incidence, mortality, survival and prevalence, and explores relevant factors such as age of manifestation and geographic locations. The statistics are compared with data from the Westernised world with particular emphasis on the United States and Australia. Potential causal agents responsible for differences in breast cancer epidemiology between Chinese and other populations are also explored. The need to minimise variability and discrepancies in methods of data acquisition, analysis and presentation is highlighted.

Nur mit Berechtigung zugänglich

The population-based data regarding specific cancer from China National Cancer Centre is available since 2003.

Average ASR has been standardised to world Segi’s population.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107 PubMedCrossRef

Parkin DM, Fernandez LMG (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(s1):S70. doi:10.1111/j.1075-122X.2006.00205.x PubMedCrossRef

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108. doi:10.3322/canjclin.55.2.74 PubMedCrossRef

Anderson BO, Yip C-H, Ramsey SD, Bengoa R, Braun S, Fitch M, Groot M, Sancho-Garnier H, Tsu VD, Global Summit Health Care Systems and Public Policy Panel (2006) Breast cancer in limited-resource countries: health care systems and public policy. Breast J 12(s1):S54. doi:10.1111/j.1075-122X.2006.00203.x PubMedCrossRef

Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917. doi:10.1002/ijc.25516 PubMedCrossRef

Jia M, Zheng R, Zhang S, Zeng H, Zou X, Chen W (2015) Female breast cancer incidence and mortality in 2011, China. J Thorac Dis 7(7):1221–1226. doi:10.3978/j.issn.2072-1439.2015.05.15 PubMedPubMedCentral

Porter P (2008) “Westernizing” women’s risks? Breast cancer in lower-income countries. The New England J Med 358(3):213–216. doi:10.1056/NEJMp0708307 CrossRef

Anderson BO, Yip C-H, Smith RA, Shyyan R, Sener SF, Eniu A, Carlson RW, Azavedo E, Harford J (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 113(8 Suppl):2221–2243. doi:10.1002/cncr.23844 PubMedCrossRef

Hortobagyi GN, Namer M, O’shaughnessy JA, Zhou Shen Z, Albain KS, De La Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu M-C, Martin M, Investigators A (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6(5):391–401. doi:10.3816/CBC.2005.n.043 PubMedCrossRef

10.

Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2(9):533–543. doi:10.1016/S1470-2045(01)00486-7 PubMedCrossRef

11.

Linos E, Spanos D, Rosner BA, Linos K, Hesketh T, Qu JD, Gao Y-T, Zheng W, Colditz GA (2008) Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst 100(19):1352–1360. doi:10.1093/jnci/djn305 PubMedPubMedCentralCrossRef

12.

Li J, Zhang B-N, Fan J-H, Pang Y, Zhang P, Wang S-L, Zheng S, Zhang B, Yang H-J, Xie X-M, Tang Z-H, Li H, Li J-Y, He J-J, Qiao Y-L (2011) A Nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11(1):1–11. doi:10.1186/1471-2407-11-364 CrossRef

13.

Leong SPL, Foulkes WD, Shen Z-Z, Liu T-J, Agarwal G, Tajima T, Paik N-S, Sandelin K, Derossis A, Cody H (2010) Is breast cancer the same disease in Asian and Western countries? World J Surg 34(10):2308–2324. doi:10.1007/s00268-010-0683-1 PubMedPubMedCentralCrossRef

14.

Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121(2):395–400. doi:10.1002/ijc.22683 PubMedCrossRef

15.

Yang G, Naghavi M, Vos T, Wang H, Lopez AD, Murray CJL, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y (2013) Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010. Lancet 381(9882):1987. doi:10.1016/S0140-6736(13)61097-1 PubMedCrossRef

16.

Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, He J (2014) Annual report on status of cancer in China, 2010. Chin J Cancer Res 26(1):48–58. doi:10.3978/j.issn.1000-9604.2014.01.08 PubMedPubMedCentral

17.

Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, He J (2013) Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 25(1):10–21. doi:10.3978/j.issn.1000-9604.2012.12.04 PubMedPubMedCentral

18.

Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P, Li GL, Wu LY, He J (2012) Report of incidence and mortality in China cancer registries, 2008. Chin J Cancer Res 24(3):171–180. doi:10.1007/s11670-012-0171-2 PubMedPubMedCentralCrossRef

19.

Chen WQ, Zeng HM, Zheng RS, Zhang SW, He J (2012) Cancer incidence and mortality in China, 2007. Chin J Cancer Res 24(1):1–8. doi:10.1007/s11670-012-0001-6 PubMedPubMedCentralCrossRef

20.

Chen WQ, Zhang SW, Zou XN, Zhao P (2011) Cancer incidence and mortality in China, 2006. Chin J Cancer Res 23(1):3–9. doi:10.1007/s11670-011-0003-9 PubMedPubMedCentralCrossRef

21.

National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2009) 2008 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2005. Military Medical Science Press, Beijing

22.

National Office for Cancer Prevention and Control, National Cantreal Cancer Registry, Disease Prevention and Control Bureau MOH (2008) China cancer registration annual report 2004. Peking Union Medical College Press, Beijing

23.

Huang Z-Z, Chen W-Q, Chun-Xiao W, Rong-Shou Z, Jian-Guo C, Nian-Nian Y, Ning W, Si-Wei Z, Ying X (2012) Incidence and mortality of female breast cancer in China—a report from 32 Chinese cancer registries, 2003–2007. TUMOR 32(6):435–439. doi:10.3781/j.issn.1000-7431.2012.06.007

24.

Chen W, Zheng R, Zeng H, Zhang S, He J (2015) Annual report on status of cancer in China, 2011. Chin J Cancer Res 27(1):2–12. doi:10.3978/j.issn.1000-9604.2015.01.06 PubMedPubMedCentralCrossRef

25.

Australian Institute of Health and Welfare (2016) Australian cancer incidence and mortality books: breast cancer. Australian Institute of Health and Welfare, Canberra

26.

U.S. Cancer Statistics Working Group (2015) United States cancer statistics: 1999–2012 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta

27.

Australian Institute of Health and Welfare, Cancer Australia (2012) Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Australian Institute of Health and Welfare, Canberra

28.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F (eds) (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon

29.

Chen W, Zheng R, Zeng H, Zhang S, Li G, Wu L, He J (2013) Incidence and mortality of breast cancer in China, 2008. Thoracic Cancer 4(1):59–65. doi:10.1111/j.1759-7714.2012.00165.x CrossRef

30.

Zeng H, Zheng R, Zhang S, Zou X, Chen W (2013) Incidence and mortality of female breast cancer in China, 2009. Thoracic Cancer 4(4):400–404. doi:10.1111/1759-7714.12037 CrossRef

31.

Zeng H, Zheng R, Zhang S, Zou X, Chen W (2014) Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J Thorac Dis 6(5):466–470. doi:10.3978/j.issn.2072-1439.2014.03.03 PubMedPubMedCentral

32.

Jemal A, Center MM, Desantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19(8):1893–1907. doi:10.1158/1055-9965.epi-10-0437 CrossRef

33.

Hulka BS, Moorman PG (2001) Breast cancer: hormones and other risk factors. Maturitas 38(1):103–113. doi:10.1016/S0378-5122(00)00196-1 PubMedCrossRef

34.

Wang N, Yuan Y-N, Rong-Shou Z, Sun X, Wang Q-S, He Y-T, Chen W-Q (2013) An analysis on difference of cancer incidence between urban and rural areas in China 2009. China Cancer 22(3):168–173

35.

Li L, Jia J, Jian-Bing W, Mayineur N, You-Lin Q, Paolo B (2012) Attributable causes of breast cancer and ovarian cancer in China: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res 24(1):9–17. doi:10.1007/s11670-012-0009-y PubMedPubMedCentralCrossRef

36.

Li N, Zheng R-S, Zhang S-W, Zou X-N, Zeng H-M, Dai Z, Wan-Qing C (2012) Analysis and prediction of breast cancer incidence trend in China. Chinese Journal of Preventive Medicine 46(8):703–707PubMed

37.

Fan L, Zheng Y, Yu K-D, Liu G-Y, Wu J, Lu J-S, Shen K-W, Shen Z-Z, Shao Z-M (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117(2):409–416. doi:10.1007/s10549-008-0303-z PubMedCrossRef

38.

Wang Q, Li J, Zheng S, Li J-Y, Pang Y, Huang R, Zhang B-N, Zhang B, Yang H-J, Xie X-M, Tang Z-H, Li H, He J-J, Fan J-H, Qiao Y-L (2012) Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China. BMC Cancer 12(1):122PubMedPubMedCentralCrossRef

39.

Lu WL, De Bock GH, Li HX, Qian BY, Wang Y, Jansen L, Huang GW, Tang NJ, Sun Z, Chen KX (2010) The clinical characteristics and prognosis of Chinese early stage breast cancer patients: a retrospective study. Breast J 16(3):331–333. doi:10.1111/j.1524-4741.2010.00903.x PubMedCrossRef

40.

Hui L, Zhong-Hua T, Hui L, Jian-Jun H, Qiong W, Yuan H, You-Lin Q, Yi P, Jia-Yuan L, Jin-Hu F, Jing L, Rong H, Bao-Ning Z, Bin Z, Hong-Jian Y, Xiao-Ming X (2014) Risk factors for breast cancer among Chinese women: a 10-year nationwide multicenter cross-sectional study. J Epidemiol 24(1):67CrossRef

41.

National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2010) 2009 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2006. Military Medical Science Press, Beijing

42.

National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2011) 2010 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2007. Military Medical Science Press, Beijing

43.

Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis D, Chen H, Feuer E, Cronin KE (2013) SEER cancer statistics review, 1975–2011. National Cancer Institute, Bethesda, Rockville

44.

Australian Bureau of Statistics (2013) ABS deaths, Australia (cat. no. 3302.0). Australian Bureau of Statistics, Canberra

45.

Kulkarni SC, Levin-Rector A, Ezzati M, Murray CJ (2011) Falling behind: life expectancy in US counties from 2000 to 2007 in an international context. Population Health Metrics 9(1):16. doi:10.1186/1478-7954-9-16 PubMedPubMedCentralCrossRef

46.

National Center for Health Statistics (2014) Health, United States, 2013: with special feature on prescription drugs. National Center for Health Statistics, Hyattsville

47.

Ferlay J, Héry C, Autier P, Sankaranarayanan R (2010) Global burden of breast cancer. In: Christopher LI (ed) Breast cancer epidemiology. Springer, New York, pp 1–19. doi:10.1007/978-1-4419-0685-4_1 CrossRef

48.

Bray F, Mccarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6(6):229–239. doi:10.1186/bcr932 PubMedPubMedCentralCrossRef

49.

Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PSF, Lau EMC, Wong CM (2002) Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer 87(9):982–988. doi:10.1038/sj.bjc.6600583 PubMedPubMedCentralCrossRef

50.

Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S (2004) The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 108(6):901–906. doi:10.1002/ijc.11661 PubMedCrossRef

51.

Chen W-Q, Zheng R-S, Wang N, He Y-T, Wang Q-S, Sun X-B, He J (2013) Comparing study of cancer incidence between east and middle-west region in China. China Cancer 22(3):1

52.

Fan L, Strasser-Weippl K, Li J-J, St Louis J, Finkelstein DM, Yu K-D, Chen W-Q, Shao Z-M, Goss PE (2014) Breast cancer in China. Lancet Oncol 15(7):e279. doi:10.1016/S1470-2045(13)70567-9 PubMedCrossRef

53.

Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO, Hall P, Mow B (2005) Profound changes in breast cancer incidence may reflect changes into a westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113(2):302–306. doi:10.1002/ijc.20561 PubMedCrossRef

54.

Zhang Y, Bu Y, Gao H (2013) Rural–urban disparities of breast cancer patients in China. Med Oncol 30(1):1–7. doi:10.1007/s12032-012-0387-5

55.

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin. doi:10.3322/caac.21338

56.

Zhao P, Dai M, Chen W, Li N (2010) Cancer trends in China. Jpn J Clin Oncol 40(4):281–285. doi:10.1093/jjco/hyp187 PubMedCrossRef

57.

Goss PE, Sheikine Y, Chen Z, Qiao Y-L, Shao Z, Wu Y-L, Fan D, Chow LWC, Wang J, Zhang Q, Yu S, Strasser-Weippl K, Shen G, He J, Purushotham A, Sullivan R, Badwe R, Banavali SD, Nair R, Kumar L, Parikh P, Subramanian S, Lee-Bychkovsky BL, Chaturvedi P, Iyer S, Shastri SS, Digumarti R, Soto-Perez-De-Celis E, Adilbay D, Semiglazov V, Orlov S, Kaidarova D, Tsimafeyeu I, Fan L, Tatishchev S, Danishevskiy KD, Hurlbert M, Vail C, St Louis J, Chan A, Li J, Chavarri-Guerra Y, Liedke PER, Pramesh CS, Badovinac-Crnjevic T (2014) Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15(5):489. doi:10.1016/S1470-2045(14)70029-4 PubMedCrossRef

58.

Wang B, He M, Wang L, Engelgau MM, Zhao W, Wang L (2013) Breast cancer screening among adult women in China, 2010. Prev Chronic Dis 10(11):E183. doi:10.5888/pcd10.130136 PubMedPubMedCentral

59.

Zhang S-W, Chen W-Q, Kong L-Z, Zhao P (2007) An annual report: cancer incidence in 35 cancer registries in China, 2003. China Cancer 16(7):494–507

60.

Chen W, Zheng R, Zeng H, Zhang S, Jie H (2015) Annual report on status of cancer in China, 2011. Chin J Cancer Res 27(1):2–12. doi:10.3978/j.issn.1000-9604.2015.01.06 PubMedPubMedCentralCrossRef

61.

Yang L, Li L-D, Chen Y-D, Parkin DM (2006) Time trends, estimates and projects for breast cancer incidence and mortality in China. Chinese J Oncol 28(6):438–440

62.

Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon

63.

Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34(2):405–412. doi:10.1093/ije/dyh414 PubMedCrossRef

64.

Leung G, Thach T, Lam T, Hedley A, Foo W, Fielding R, Yip P, Lau E, Wong C (2002) Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. British J Cancer 87(9):982–988CrossRef

65.

Wong IOL, Cowling BJ, Schooling CM, Leung GM (2007) Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer 121(7):1556–1563. doi:10.1002/ijc.22731 PubMedCrossRef

66.

Wong IOL, Schooling CM, Cowling BJ, Leung GM (2015) Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends. Br J Cancer 112(1):167–170. doi:10.1038/bjc.2014.532 PubMedCrossRef

67.

Jin F, Devesa SS, Zheng W, Blot WJ, Fraumeni JJF, Gao YT (1993) Cancer incidence trends in urban Shanghai, 1972–1989. Int J Cancer 53(5):764–770. doi:10.1002/ijc.2910530510 PubMedCrossRef

68.

Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JJF, Gao YT (1999) Cancer incidence trends in urban Shanghai, 1972–1994: an update. Int J Cancer 83(4):435–440. doi:10.1002/(SICI)1097-0215(19991112)83:4<435:AID-IJC1>3.0.CO;2-J PubMedCrossRef

69.

Yu H, Harris RE, Gao YT, Gao R, Wynder EL (1991) Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20(1):76–81. doi:10.1093/ije/20.1.76 PubMedCrossRef

70.

Chen W-Q, Zheng R-S, Zeng H-M, Zhang S-W, Zhao P, He J (2012) Trend analysis and projection of cancer incidence in China between 1989 and 2008. Chinese J Oncol 34(7):517–524

71.

Yang L, Parkin DM, Ferlay J, Li LA, Chen YD (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomark Prev 14(1):243–250

72.

Wang N, Zhu W-X, Xing X-M, Yang L, Li P-P, You W-C (2011) Time trends of cancer incidence in urban Beijing, 1998–2007. Chin J Cancer Res 23(1):15–20. doi:10.1007/s11670-011-0015-5 PubMedPubMedCentralCrossRef

73.

Youlden DR, Cramb SM, NaM Dunn, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36(3):237PubMedCrossRef

74.

Ziegler RG, Anderson WF, Gail MH (2008) Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst 100(19):1339–1341. doi:10.1093/jnci/djn330 PubMedCrossRef

75.

Population Census Office under States Council Department of Population and Employment Statistics, China National Bureau of Statistics (2011) Major figures on 2010 population census of China. China Satistics Press, Beijing

76.

Australian Institute of Health and Welfare (2013) Breast Screen Australia monitoring report 2010–2011. Cancer series no. 77. Cat. no. CAN 74. Australian Institute of Health and Welfare, Canberra

77.

Stewart BW, Wild CP (eds) (2014) World cancer report 2014. WHO Press, World Health Organization, Geneva

78.

Berry DA, Feuer EJ, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Cancer I, Surveillance Modeling Network C, Collaborators C (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. The New England J Med 353(17):1784–1792. doi:10.1056/NEJMoa050518 CrossRef

79.

Zhou M-G, Wang X-F, Hu J-P, Li G-L, Chen W-Q, Zhang S-W, Wan X, Wang L-J, Xiang C, Hu Y-S, Yang G-H (2010) Geographic distribution of cancer mortality in China, 2004–2005. Chinese J Prev Med. doi:10.3760/cma.j.issn.0253-9624.2010.04.06

80.

He M, Guo Q, Hu G (2011) Reversed urban–rural differences in breast cancer mortality (China, 2002–2008). Breast Cancer Res Treat 126(1):231–234. doi:10.1007/s10549-010-1276-2 PubMedCrossRef

81.

Youlden DR, Cramb SM, Yip CH, Baade PD (2014) Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol & Med 11(2):101

82.

National Office for Cancer Prevention and Control, National Cantreal Cancer Registry, Disease Prevention and Control Bureal Ministry of Health (2010) National report of cancer mortality: report of the third national retrospective sample survey of mortality, China. People’s Medical Publishing House Co., LTD, Beijing

83.

Yang L, Parkin DM, Li LD, Chen YD (2003) Time trends in cancer mortality in China: 1987–1999. Int J Cancer 106(5):771–783. doi:10.1002/ijc.11300 PubMedCrossRef

84.

Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer 90(11):2157–2166. doi:10.1038/sj.bjc.6601813 PubMedPubMedCentral

85.

Luo J, Hu FB (2002) Time trends of obesity in pre-school children in China from 1989 to 1997. Inter J Obes and Relat Disord 26(4):553–558. doi:10.1038/sj.ijo.0801944 CrossRef

86.

Shu XO, Zheng W, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, Hebert JR, Ruan Z, Gao YT (2001) Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94(3):449–455. doi:10.1002/ijc.1487 PubMedCrossRef

87.

Matthews CE, Shu XO, Jin F, Dai Q, Hebert JR, Ruan ZX, Gao YT, Zheng W (2001) Lifetime physical activity and breast cancer risk in the Shanghai breast cancer study. Br J Cancer 84(7):994–1001. doi:10.1054/bjoc.2000.1671 PubMedPubMedCentralCrossRef

88.

Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, Mctiernan A, Alfano CM (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104(11):815–840. doi:10.1093/jnci/djs207 PubMedPubMedCentralCrossRef

89.

Sankaranarayanan R, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Swaminathan R, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N, Brenner H, Chen K, Chen JG, Chia KS, Law SCK, Ahn Y-O, Xiang YB (2010) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11(2):165–173. doi:10.1016/S1470-2045(09)70335-3 PubMedCrossRef

90.

Chen JG, Li WG, Shen ZC, Yao HY, Zhang BC, Zhu YR (1998) Population-based cancer survival in Qidong, People’s Republic of China. In: Sankaranarayanan R, Black RJ, Parkin DM (eds) Cancer survical in developing countries, vol 145. International Agency for Research on Cancer, Lyon, pp 27–35

91.

Jin F, Xiang YB, Gao YT (1998) Cancer survival in Shanghai, People’s Republic of China. In: Sankaranarayanan R, Black RJ, Parkin DM (eds) Cancer survial in developing countries. International Agency for Research on Cancer, Lyon, pp 37–50

92.

Xuiang YB, Jin F, Gao YT (2011) Cancer survival in Shanghai, China, 1992–1995. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Research on Cancer, Lyon, pp 55–68

93.

Chen JG, Zhu J, Zhang YH, Lu JH (2011) Cancer survival in Qidong, China, 1992−2000. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Reearch on Cancer, Lyon, pp 43–53

94.

Xishan H, Chen K, Min H, Shufen D, Jifang W (2011) Cancer survival in Tianjin, China, 1991–1999. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Research on Cancer, Lyon, pp 69–84

95.

Black RJ, Parkin DM, Sankaranarayanan R, International Agency for Research On C (1998) Cancer survival in developing countries, vol no. 145. International Agency for Research on Cancer, Lyon

96.

Coleman MP, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Quaresma M, Verdecchia A, Storm HH, Young JL, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Group CW (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9(8):730–756. doi:10.1016/S1470-2045(08)70179-7 PubMedCrossRef

97.

Brenner H, Sant M, Francisci S, De Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Group EW (2009) Long-term survival expectations of cancer patients in Europe in 2000–2002. European J Cancer (Oxford, England: 1990) 45(6):1028–1041. doi:10.1016/j.ejca.2008.11.005 CrossRef

98.

Sankaranarayanan R, Swaminathan R, Lucas E (2011) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). vol IARC Scientific Publications volume 162. International Agency for Research on Cancer, Lyon

99.

Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK (2003) Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program. Oncologist 8(6):541–552. doi:10.1634/theoncologist.8-6-541 PubMedCrossRef

100.

Coleman MP, Hatcher J, Mcgahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Forman D, Morris EJ, Middleton R, Steward J, Richards MA, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Group IMW (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138. doi:10.1016/S0140-6736(10)62231-3 PubMedPubMedCentralCrossRef

101.

Zhu J, Chen J-G, Chen Y-S, Zhang Y-H, Ding L-L, Chen T-Y (2014) Female breast cancer survival in Qidong, China, 1972-2011: a population-based study. BMC Cancer 14(1):318. doi:10.1186/1471-2407-14-318 PubMedPubMedCentralCrossRef

102.

Qi-Jun W, Zhu W-X, Xing X-M (2006) Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years. Chinese J Oncol 28(3):208–210

103.

Tan BKT, Lim GH, Czene K, Hall P, Chia KS (2009) Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast cancer res: BCR 11(1):R4–R4. doi:10.1186/bcr2219 PubMedPubMedCentralCrossRef

104.

Kuo RNC, Chung K-P, Lai M-S (2011) Effect of the pay-for-performance program for breast cancer care in Taiwan. J Oncol Pract 7(3 Suppl):e8s–e15s. doi:10.1200/JOP.2011.000314 PubMedPubMedCentral

105.

Schopper D, De Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. European J Cancer (Oxford, England: 1990) 45(11):1916–1923. doi:10.1016/j.ejca.2009.03.022 CrossRef

106.

Cronin KA, Feuer EJ, Clarke LD, Plevritis SK (2006) Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 36:112PubMedCrossRef

107.

Gondos A, Bray F, Hakulinen T, Brenner H, The ESWG, Group ESW (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 20(3):564–573. doi:10.1093/annonc/mdn639 CrossRef

108.

Giordano SH, Buzdar AU, Smith TL, Kau S-W, Yang Y, Hortobagyi GN (2004) Is breast cancer survival improving? Cancer 100(1):44–52. doi:10.1002/cncr.11859 PubMedCrossRef

109.

Goldhirsch A, Glick JH, Gelber RD, Coates AS, Hans-Jörg S (2001) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19(18):3817–3827PubMed

110.

Sant M, Eurocare Working G (2001) Differences in stage and therapy for breast cancer across Europe. Int J Cancer 93(6):894–901. doi:10.1002/ijc.1408 PubMedCrossRef

111.

Sant M, Bell J, Youngson J, Berrino F, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Group EW, The EWG (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422. doi:10.1002/ijc.11226 PubMedCrossRef

112.

Youlden DR, Cramb SM, Baade PD (2009) Current status of female breast cancer in Queensland: 1982 to 2006. Viertel Centre for Research in Cancer Control, Cancer Council Queensland

113.

Ries LaG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (2007) SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, Bethesda, Rockville

114.

Australian Institute of Health and Welfare, National Breast and Ovarian Cancer Centre (2009) Breast cancer in Australia: an overview, 2009. Cancer series no. 50. Cat. no. CAN 46. Australian Institute of Health and Welfare, Canberra

115.

Australian Institute of Health and Welfare, National Breast Cancer Centre (2006) Breast cancer in Australia: an overview, 2006. Cancer series no. 34. cat. no. CAN 29. Australian Institute of Health and Welfare, Canberra

116.

Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12(1):20–37. doi:10.1634/theoncologist.12-1-20 PubMedCrossRef

117.

Australian Institute of Health and Welfare, National Breast Cancer Centre (2007) Breast cancer survival by size and nodal status in Australia. Cancer Series no. 39. Cat. no. CAN 34. Australian Institute of Health and Welfare, Canberra

118.

Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132(5):1133–1145. doi:10.1002/ijc.27711 PubMedCrossRef

119.

Yu Z-G, Jia C-X, Liu L-Y, Geng C-Z, Tang J-H, Zhang J, Zhang Q, Li Y-Y, Ma Z-B (2012) The prevalence and correlates of breast cancer among women in Eastern China. PLoS One 7(6):e37784PubMedPubMedCentralCrossRef

Titel: Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence
verfasst von: Tong Li
Claudia Mello-Thoms
Patrick C. Brennan
Publikationsdatum: 25.08.2016
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2016
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-016-3947-0

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Genomic profiling of breast cancer in African-American women using MammaPrint

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie